Brentuximab vedotin, Cyclophosphamide, Dacarbazine, Dexamethasone, Doxorubicin, and Etoposide
About
Membership operator: AND
Therapies: 6
Therapies
Brentuximab vedotin (tx:ncit:C66944)
Cyclophosphamide (tx:ncit:C405)
Dacarbazine (tx:ncit:C411)
Dexamethasone (tx:ncit:C422)
Doxorubicin (tx:ncit:C456)
Etoposide (tx:ncit:C491)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) | CD30 + | Hodgkin Lymphoma | Brentuximab vedotin, Cyclophosphamide, Dacarbazine, Dexamethasone, Doxorubicin, Etoposide |